| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |